Concordia Terminates Enrollment in Cholangiocarcinoma Treatment Study

This topic has 0 replies, 1 voice, and was last updated 7 years, 7 months ago by marions.

Viewing 1 post (of 1 total)

Author

Posts
December 20, 2016 at 6:38 am #12854

marions
Moderator

This study has been stopped, but patients enrolled in their trial will continue to be treated.

Read more: http://www.nasdaq.com/article/concordia-international-shares-off-3-pre-bell-terminates-enrollment-in-cholangiocarcinoma-treatment-study-cm723096
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘New Developments’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation